眼科 ›› 2026, Vol. 35 ›› Issue (2): 121-126.doi: 10.13281/j.cnki.issn.1004-4469.2026.02.007

• 论著 • 上一篇    下一篇

严重开放性眼外伤一期缝合时玻璃体内注射曲安奈德防治增生性玻璃体视网膜病变的效果观察

崔莹  方雨新  王戈  周丹   

  1. 首都医科大学附属北京同仁医院 北京同仁眼科中心 眼科学与视觉科学北京市重点实验室,北京 100730

  • 收稿日期:2025-11-11 出版日期:2026-03-25 发布日期:2026-03-25
  • 通讯作者: 周丹,Email:13701317892@163.com
  • 基金资助:
    国家自然科学基金青年科学基金(82301210)

The effect of intravitreal injection of triamcinolone acetonide during primary suture for severe open eye trauma in preventing proliferative vitreoretinopathy

Cui Ying, Fang Yuxin, Wang Ge, Zhou Dan   

  1. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing 100730, China

  • Received:2025-11-11 Online:2026-03-25 Published:2026-03-25
  • Contact: Zhou Dan, Email: 13701317892@163.com
  • Supported by:
    National Natural Science Foundation of China-Young Scientists Fund (82301210)

摘要: 目的  观察一期缝合时玻璃体内注射曲安奈德(TA)防治严重开放性眼外伤后增生性玻璃体视网膜病变(PVR)的效果。设计  回顾性病例系列。研究对象  2023年1-12月于北京同仁医院接受一期缝合手术并即刻玻璃体内注射TA、二期接受玻璃体切除术(PPV)的III区开放性眼外伤患者13例(13眼)。男性10例,女性3例。年龄32~68岁,平均(46.5±12.3)岁。方法  PPV术中记录PVR分级。随访3~24个月,平均(12.1±7.0)个月。比较末次随访和基线时的视力、眼压、眼轴,记录视网膜脱离(RD)复位、脉络膜脱离恢复及硅油取出情况。主要指标  PVR分级,RD复位、脉络膜脱离恢复情况。结果  术中见PVR为0级者4眼(30.8%),I级0眼(0%),II级2眼(15.4%),III级4眼(30.8%),IV级3眼(23.1%)。末次随访视力为(1.25±0.90)LogMAR,较基线的(2.51±0.28)LogMAR显著提高(t=5.689,P<0.001)。末次随访眼压(11.4±3.9)mmHg,较基线的(8.4±3.4)mmHg显著提高(t=-5.555,P<0.001)。末次随访眼轴(23.28±1.72)mm,与基线的(23.20±1.56)mm无显著差异(t=-0.883,P=0.454)。9眼术前伴RD眼中,末次随访时8眼完全复位,1眼未复位。8眼术前合并脉络膜脱离眼中,末次随访时6眼完全恢复。9眼硅油填充眼中,末次随访时3眼已取出硅油。未见TA相关不良反应。结论 对严重开放性眼外伤,在一期缝合时即刻玻璃体内注射TA,可抑制或减轻PVR。

关键词: 开放性眼外伤, 增生性玻璃体视网膜病变, 曲安奈德, 玻璃体切除术

Abstract:  Objective  To evaluate the efficacy of intravitreal triamcinolone acetonide (TA) injection during primary repair surgery for severe open globe injury in preventing proliferative vitreoretinopathy (PVR). Design Retrospective case series. Participants Thirteen patients (13 eyes) with zone III open eye trauma who underwent primary surgical repair with immediate intravitreal TA injection followed by secondary PPV at Beijing Tongren Hospital between January 2023 and December 2023. The cohort included 10 males and 3 females, with ages ranging from 32 to 68 years (mean, 46.5±12.3 years). Methods PVR grading was documented during PPV. The patients were followed up for 3 to 24 months (mean, 12.1±7.0 months). Best-corrected visual acuity (BCVA), intraocular pressure (IOP), and axial length (AL) were compared between baseline and the final follow-up visit. Data on retinal reattachment, choroidal detachment resolution, and silicone oil removal were also recorded. Main Outcome Measures PVR grade, the condition of retinal reattachment and choroidal detachment recovery. Results PVR grading revealed 4 eyes (30.8%) at grade 0, 0 eye (0%) at grade I, 2 eyes (15.4%) at grade II, 4 eyes (30.8%) at grade III, and 3 eyes (23.1%) at grade IV. At the final follow-up, the mean BCVA was (1.25±0.90) LogMAR, which was significantly improved compared with the baseline value of (2.51±0.28) LogMAR (t=5.689, P<0.001). The mean IOP at final follow-up was (11.4±3.9) mmHg, showing a significant increase from the baseline value of (8.4±3.4) mmHg (t=-5.555, P<0.001). The mean AL at final follow-up was (23.28±1.72) mm, with no statistically significant difference from the baseline value of (23.20±1.56) mm (t=-0.883, P=0.454). Among the 9 eyes with preoperative retinal detachment, 8  eyes achieved complete retinal reattachment while 1 remained detached at the final follow-up. Of the 8 eyes with preoperative choroidal detachment, 6 showed complete resolution at the final follow-up. Silicone oil had been removed in 3 out of the 9 eyes that received silicone oil tamponade by the final follow-up visit. No TA-related adverse reactions were observed. Conclusions For severe open globe injury, intravitreal injection of TA during primary repair surgery can inhibit or alleviate PVR.

Key words:  Open globe injury, Proliferative vitreoretinopathy, Triamcinolone acetonide, Vitrectomy